PT3331508T - Solução de injeção hiperbárica de cloridrato de levobupivacaína compreendendo cloridrato de levobupivacaína - Google Patents

Solução de injeção hiperbárica de cloridrato de levobupivacaína compreendendo cloridrato de levobupivacaína

Info

Publication number
PT3331508T
PT3331508T PT168240034T PT16824003T PT3331508T PT 3331508 T PT3331508 T PT 3331508T PT 168240034 T PT168240034 T PT 168240034T PT 16824003 T PT16824003 T PT 16824003T PT 3331508 T PT3331508 T PT 3331508T
Authority
PT
Portugal
Prior art keywords
levobupivacaine hydrochloride
solution injection
levobupivacaine
hydrochloride
hyperbaric solution
Prior art date
Application number
PT168240034T
Other languages
English (en)
Original Assignee
Neon Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neon Laboratories Ltd filed Critical Neon Laboratories Ltd
Publication of PT3331508T publication Critical patent/PT3331508T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT168240034T 2015-07-13 2016-04-01 Solução de injeção hiperbárica de cloridrato de levobupivacaína compreendendo cloridrato de levobupivacaína PT3331508T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2641MU2015 2015-07-13

Publications (1)

Publication Number Publication Date
PT3331508T true PT3331508T (pt) 2024-12-19

Family

ID=57757071

Family Applications (1)

Application Number Title Priority Date Filing Date
PT168240034T PT3331508T (pt) 2015-07-13 2016-04-01 Solução de injeção hiperbárica de cloridrato de levobupivacaína compreendendo cloridrato de levobupivacaína

Country Status (7)

Country Link
US (1) US20190070157A1 (pt)
EP (1) EP3331508B1 (pt)
DK (1) DK3331508T3 (pt)
FI (1) FI3331508T3 (pt)
LT (1) LT3331508T (pt)
PT (1) PT3331508T (pt)
WO (1) WO2017009862A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250082622A1 (en) * 2023-09-12 2025-03-13 Fresenius Kabi Austria Gmbh Bupivacaine liquid formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8802564D0 (sv) * 1988-07-08 1988-07-08 Astra Ab New synergistic preparations and a new method of alleviation of pain
KR100695588B1 (ko) * 1997-11-19 2007-03-14 다윈 디스커버리 리미티드 마취용 제형물
US6075059A (en) * 1999-02-24 2000-06-13 The Ohio State University Compositions for dental anesthesia
JP2002069006A (ja) * 2000-08-22 2002-03-08 Maruishi Pharmaceutical Co Ltd 局所麻酔剤組成物
CN1628665A (zh) * 2003-12-17 2005-06-22 北京博尔达生物技术开发有限公司 注射用左布比卡因冻干粉针剂及制备方法

Also Published As

Publication number Publication date
EP3331508A4 (en) 2019-06-19
EP3331508B1 (en) 2024-08-14
US20190070157A1 (en) 2019-03-07
FI3331508T3 (fi) 2024-11-14
WO2017009862A1 (en) 2017-01-19
EP3331508C0 (en) 2024-08-14
EP3331508A1 (en) 2018-06-13
LT3331508T (lt) 2024-12-27
DK3331508T3 (da) 2024-11-18

Similar Documents

Publication Publication Date Title
SG10201912792YA (en) Therapeutic compounds and methods
SMT202200358T1 (it) Composizioni e metodi di rilascio degli agenti terapeutici
SG10201802106TA (en) Pharmaceutical composition of s-ketamine hydrochloride
SG10201802104QA (en) Pharmaceutical composition of s-ketamine hydrochloride
ZA201706257B (en) Treatment of wood
ZA201802329B (en) Hppd variants and methods of use
ZA201903467B (en) Transdermal delivery of large agents
HUE056424T2 (hu) Eljárások hatóanyagoknak a nyirokrendszerbe való bejuttatására
ZA201902090B (en) Combination treatments comprising administration of imidazopyrazinones
IL285882A (en) Medicinal uses for l–4–chlorokynurenine
IL254273A0 (en) Variants of protoxin-ii and methods of use
IL282508A (en) Variants of protoxin-II and methods of use
IL255530A (en) Efflux-pump inhibitors and therapeutic uses thereof
PT3331516T (pt) Solução de injeção hiperbárica de cloridrato de ropivacaína e processo para a sua preparação
PT3331508T (pt) Solução de injeção hiperbárica de cloridrato de levobupivacaína compreendendo cloridrato de levobupivacaína
DK3453388T3 (da) Farmaceutisk opløsning omfattende dopaminhydrochlorid
GB201512139D0 (en) Methods of treatment
GB201608599D0 (en) Treatment of opioid tollerence
PT3453388T (pt) Solução farmacêutica compreendendo cloridrato de dopamina
GB201513922D0 (en) Treatment of hyperpigmentation
TWM489593U (en) Improved structure of base for coat-hanging rack
TH1501005346A (th) องค์ประกอบทางเภสัชกรรมของเอส-คีตามีน ไฮโดรคลอไรด์